Current trends in the management of adamantinoma of long bones. An international study
- PMID: 10954102
- DOI: 10.2106/00004623-200008000-00009
Current trends in the management of adamantinoma of long bones. An international study
Abstract
Background: Adamantinoma of long bones is a rare tumor. Published reviews of the orthopaedic management of adamantinoma have involved limited follow-up of small numbers of patients. The oncological aggressiveness of this tumor is unknown. Limb salvage is currently the treatment of choice for most adamantinomas. The purpose of this study was to evaluate the characteristics of adamantinoma of long bones as well as the oncological outcome and the complications of limb salvage operations.
Methods: A retrospective study was designed to evaluate the clinical outcomes of limb salvage operations for the treatment of adamantinoma. Data on seventy biopsy-proven cases of adamantinoma treated between 1982 and 1992 at twenty-three different cancer centers in Europe and North America were obtained.
Results: The median duration of follow-up was 7.0 years. The male:female ratio was 3:2, and the mean age was thirty-one years. Limb salvage was attempted in 91 percent (sixty-four) of the seventy patients, and the final rate of limb preservation was 84 percent (fifty-nine of seventy). Wide operative margins were obtained in 92 percent (fifty-eight) of sixty-three patients. An intercalary allograft was used to reconstruct the segmental bone defect in 51 percent (thirty-six) of the seventy patients. Reconstruction-related complications occurred in 48 percent (thirty) of sixty-two patients. Nonunion and fracture were the most common complications, occurring in 24 percent (fifteen) and 23 percent (fourteen) of sixty-two patients, respectively. Kaplan-Meier analysis demonstrated a rate of local recurrence of 18.6 percent at ten years. Wide operative margins were associated with a lower rate of local recurrence than marginal or intralesional margins were (p < 0.00005). Kaplan-Meier analysis showed a survival rate of 87.2 percent at ten years. There were no significant relationships between survival and the stage of the tumor (p = 0.058), duration of symptoms (p = 0.90), gender (p = 0.79), or wide operative margins (p = 0.14).
Conclusions: Current treatment of adamantinoma, including en bloc tumor resection with wide operative margins and limb salvage, provides lower rates of local recurrence than has been previously reported. In the present study, the limb preservation rate was 84 percent (fifty-nine of seventy), and the survival rate was 87.2 percent at ten years. The rate of complications related to the limb reconstruction was high.
Similar articles
-
Hemicortical resection and inlay allograft reconstruction for primary bone tumors: a retrospective evaluation in the Netherlands and review of the literature.J Bone Joint Surg Am. 2015 May 6;97(9):738-50. doi: 10.2106/JBJS.N.00948. J Bone Joint Surg Am. 2015. PMID: 25948521 Review.
-
Adamantinoma of bone: Long-term follow-up of 46 consecutive patients.J Surg Oncol. 2018 Dec;118(7):1150-1154. doi: 10.1002/jso.25269. Epub 2018 Oct 17. J Surg Oncol. 2018. PMID: 30332521
-
Adamantinoma of the long bones. A clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion, and biological behavior.J Bone Joint Surg Am. 1994 Oct;76(10):1482-99. doi: 10.2106/00004623-199410000-00008. J Bone Joint Surg Am. 1994. PMID: 7929496
-
Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 Cases.J Bone Joint Surg Am. 2020 Oct 7;102(19):1703-1713. doi: 10.2106/JBJS.19.01056. J Bone Joint Surg Am. 2020. PMID: 33027124 Free PMC article.
-
Chondrosarcoma of the pelvis. A review of sixty-four cases.J Bone Joint Surg Am. 2001 Nov;83(11):1630-42. J Bone Joint Surg Am. 2001. PMID: 11701784 Review.
Cited by
-
Tibia Adamantinoma Resection and Reconstruction with a Custom-Made Total Tibia Endoprosthesis: A Case Report with 8-Year Follow-Up.Case Rep Orthop. 2018 Jun 6;2018:3656913. doi: 10.1155/2018/3656913. eCollection 2018. Case Rep Orthop. 2018. PMID: 29984021 Free PMC article.
-
Adamantinoma Arising in the Distal End of the Fibula.Rare Tumors. 2017 Mar 24;9(1):6823. doi: 10.4081/rt.2017.6823. eCollection 2017 Mar 24. Rare Tumors. 2017. PMID: 28458791 Free PMC article.
-
Primary adamantinoma of the rib. Unusual presentation for a bone neoplasm of uncertain origin.Pathol Oncol Res. 2008 Dec;14(4):497-502. doi: 10.1007/s12253-008-9009-0. Epub 2008 Apr 12. Pathol Oncol Res. 2008. PMID: 18409022
-
Epidemiological Study of Adamantinoma from US Surveillance, Epidemiology, and End Results Program: III Retrospective Analysis.J Oncol. 2020 Jun 16;2020:2809647. doi: 10.1155/2020/2809647. eCollection 2020. J Oncol. 2020. PMID: 32612653 Free PMC article.
-
A Case of Metastatic Adamantinoma That Responded Well to Sunitinib.Case Rep Oncol Med. 2016;2016:5982313. doi: 10.1155/2016/5982313. Epub 2016 Aug 17. Case Rep Oncol Med. 2016. PMID: 27630780 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials